Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Nov 23, 2012 9:58pm
163 Views
Post# 20638667

RE: True Test...& Overhang & Warrants

RE: True Test...& Overhang & Warrants

Fire:

[S] Thanks for the reminder on the warrants:

1. Dec 10, 2012: 5 326 782 @ $0.884 = $4 758 843

2. Feb 20, 2013: 6 709 028 @ $1.008 = $6 834 462 (portion required to top up funds to buy the remaining % of stream use as collateral for a 51 day loan?)

for $11 593 305 additional funds from the warrants to Feb 20 2013; see pg 27 of the October presentation:

https://www.snl.com/Cache/1500043918.PDF?D=&O=PDF&IID=4288058&Y=&T=&FID=1500043918

WIth the POG going up ~$50 in Nov to date it appears that the $2,000 COULD be possible,as the $US election is behind us and the $US is finally rerflecting QE ad naseum.

BWDIK? At 2,200 tpd mill throughput, OP (or other contribution) steady state to be optimized to 1 000 - 1 200 tpd (@ 2.5 - 3.0 gpt with the UG to 800 - 1 000 tpd @ 6.00 gpt. Thus at 2 200 and 1 200 open pit and 1 000 UG tonnes working in conjunction with an increasing POG and reduced cost per ounce ... things COULD get interesting.

Cheers

Stanley

Bullboard Posts